Search results
Mar 24, 2021 · The Board of Directors of GlaxoSmithKline plc (“GSK”), the majority shareholder of Galvani Bioelectronics (“Galvani”), today announced the termination of Moncef Slaoui as Chair of the Galvani Board of Directors, effective immediately.
Mar 24, 2021 · Dr. Slaoui came to Operation Warp Speed from GSK, where he was in charge of developing vaccines. He headed the Trump administration’s vaccine acceleration efforts from May until January.
Mar 4, 2022 · Former Operation Warp Speed chief Moncef Slaoui, who GlaxoSmithKline fired last year because of a sexual harassment claim, is returning (PDF) $3.86 million to the company, according to its annual...
- Kevin Dunleavy
Mar 24, 2021 · Moncef Slaoui, former scientific head of Operation Warp Speed, the government's COVID-19 vaccine development effort, was fired by GlaxoSmithKline after an internal investigation found he...
Mar 25, 2021 · Moncef Slaoui, the former scientific director of COVID-19 vaccine development at Operation Warp Speed during the Trump administration, has been fired from a joint venture of GlaxoSmithKline...
- Reporter
- 11 min
Mar 24, 2021 · Moncef Slaoui, who led the Trump administration's COVID-19 vaccine development efforts under Operation Warp Speed, has lost his job as chairman of the board at a medical device startup.
People also ask
Who is Moncef Slaoui?
Did GlaxoSmithKline fire Moncef Slaoui?
Did GSK Slaoui get a cash return from Galvani Bioelectronics?
Who is Dr Slaoui & why did he join operation warp speed?
Moncef Slaoui, GSK’s Chairman of Global Vaccines, who was instrumental in establishing GSK’s investments in the field of bioelectronics, will chair the board of the new company. He said:
